Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
GLP-1 drugs first helped people manage Type 2 diabetes. Today, doctors also use them widely for weight loss. Researchers are now exploring whether these medications could also affect breast cancer risk and outcomes. Early studies suggest that GLP-1 drugs may…
The growing use of GLP-1 weight-loss medicines is changing more than just body weight. Doctors and aesthetic specialists are seeing more patients who notice changes in their face after losing a large amount of weight. As a result, demand for…
Rapid weight loss from medications such as Ozempic can cause noticeable changes in the face. Doctors are seeing more patients with sagging skin, hollow cheeks, and sudden hair shedding after significant weight loss. With millions of people using these medications,…
A new study published in The BMJ offers encouraging news for adults with type 2 diabetes and heart conditions. Researchers found that tirzepatide, the main ingredient in Mounjaro, may reduce the risk of major heart problems. The study suggests that…
Nearly one in four Latino adults in the U.S. deal with obesity, and for a long time, standard advice like “eat less and move more” just wasn’t enough for many. Enter GLP-1 drugs brand names like Ozempic, Wegovy, Mounjaro, and…
Eli Lilly is still one of the biggest names in diabetes and weight-loss drugs. Most of its success comes from three main products: two weekly shots and a new daily pill. Investors are eager to see how well these drugs…
A new study is raising concerns about the mental health of type 2 diabetes patients who stop taking GLP-1 receptor agonist drugs. Until now, doctors haven’t had much information about how stopping these medications affects patients psychologically. To find out…
New survey data indicates that patient utilization of GLP-1 medications has reached an unprecedented peak. Eleven percent of adults now report the current use of a GLP-1 drug for weight reduction. This metric represents a significant increase from the 3…
Economic and pharmaceutical pressures are coming together to change how consumers behave in the snack food market. PepsiCo CEO Ramon Laguarta has pointed out two main factors influencing household buying habits. First, rising fuel costs are limiting discretionary spending for…
A new report from a research group called Big Chalk Analytics shows that oral weight-loss pills are about to bring in a massive wave of new patients. Many people who dislike needles are looking forward to a simple, daily pill…